These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

601 related items for PubMed ID: 28552299

  • 1. Transarterial chemoembolization in hepatocellular carcinoma with portal vein tumor thrombosis: a systematic review and meta-analysis.
    Silva JP, Berger NG, Tsai S, Christians KK, Clarke CN, Mogal H, White S, Rilling W, Gamblin TC.
    HPB (Oxford); 2017 Aug; 19(8):659-666. PubMed ID: 28552299
    [Abstract] [Full Text] [Related]

  • 2. Comprehensive treatments for hepatocellular carcinoma with tumor thrombus in major portal vein.
    Ye HH, Ye JZ, Xie ZB, Peng YC, Chen J, Ma L, Bai T, Chen JZ, Lu Z, Qin HG, Xiang BD, Li LQ.
    World J Gastroenterol; 2016 Apr 07; 22(13):3632-43. PubMed ID: 27053855
    [Abstract] [Full Text] [Related]

  • 3. [Transarterial chemoembolization (TACE) of the hepatocellular carcinoma (HCC) in patients with portal vein thrombosis--experiences].
    Herber S, Pitton M, Mönch C, Schneider J, Manzl N, Kummer I, Kanzler S, Schuchmann M, Junginger T, Düber C, Otto G.
    Zentralbl Chir; 2007 Aug 07; 132(4):306-15. PubMed ID: 17724633
    [Abstract] [Full Text] [Related]

  • 4. Outcome of transarterial chemoembolization in Egyptian patients with hepatocellular carcinoma and branch portal vein thrombosis.
    Abdella H, Shaker MK, Montasser IF, Sobhi M, Aly H, Sayed A, Saleh S, El Dorry A.
    Indian J Gastroenterol; 2018 Mar 07; 37(2):127-132. PubMed ID: 29532323
    [Abstract] [Full Text] [Related]

  • 5. Combined endovascular brachytherapy, sorafenib, and transarterial chemobolization therapy for hepatocellular carcinoma patients with portal vein tumor thrombus.
    Zhang ZH, Liu QX, Zhang W, Ma JQ, Wang JH, Luo JJ, Liu LX, Yan ZP.
    World J Gastroenterol; 2017 Nov 21; 23(43):7735-7745. PubMed ID: 29209114
    [Abstract] [Full Text] [Related]

  • 6. Prognostic factors for survival after transarterial chemoembolization combined with microwave ablation for hepatocellular carcinoma.
    Ni JY, Sun HL, Chen YT, Luo JH, Chen D, Jiang XY, Xu LF.
    World J Gastroenterol; 2014 Dec 14; 20(46):17483-90. PubMed ID: 25516662
    [Abstract] [Full Text] [Related]

  • 7. Appropriate treatment strategies improve survival of hepatocellular carcinoma patients with portal vein tumor thrombus.
    Ye JZ, Zhang YQ, Ye HH, Bai T, Ma L, Xiang BD, Li LQ.
    World J Gastroenterol; 2014 Dec 07; 20(45):17141-7. PubMed ID: 25493028
    [Abstract] [Full Text] [Related]

  • 8. Sorafenib With and Without Transarterial Chemoembolization for Advanced Hepatocellular Carcinoma With Main Portal Vein Tumor Thrombosis: A Retrospective Analysis.
    Zhang Y, Fan W, Wang Y, Lu L, Fu S, Yang J, Huang Y, Yao W, Li J.
    Oncologist; 2015 Dec 07; 20(12):1417-24. PubMed ID: 26446238
    [Abstract] [Full Text] [Related]

  • 9. Anlotinib followed by transarterial chemoembolization and radiofrequency ablation is a safe and effective initial treatment for hepatocellular carcinoma patients with portal vein tumor thrombus: A retrospective case series study.
    Wang J, Li X, Wang F, Shi D, Zhang J.
    J Cancer Res Ther; 2021 Jul 07; 17(3):619-624. PubMed ID: 34269290
    [Abstract] [Full Text] [Related]

  • 10. Survival benefit of hepatic resection versus transarterial chemoembolization for hepatocellular carcinoma with portal vein tumor thrombus: a systematic review and meta-analysis.
    Zhang XP, Wang K, Li N, Zhong CQ, Wei XB, Cheng YQ, Gao YZ, Wang H, Cheng SQ.
    BMC Cancer; 2017 Dec 28; 17(1):902. PubMed ID: 29282010
    [Abstract] [Full Text] [Related]

  • 11. Efficacy of transarterial chemoembolization for hepatocellular carcinoma with portal vein thrombosis: a meta-analysis.
    Leng JJ, Xu YZ, Dong JH.
    ANZ J Surg; 2016 Oct 28; 86(10):816-820. PubMed ID: 25088384
    [Abstract] [Full Text] [Related]

  • 12. Transarterial chemoembolization for hepatocellular carcinoma with portal vein tumor thrombus: a meta-analysis.
    Xue TC, Xie XY, Zhang L, Yin X, Zhang BH, Ren ZG.
    BMC Gastroenterol; 2013 Apr 08; 13():60. PubMed ID: 23566041
    [Abstract] [Full Text] [Related]

  • 13. Radiotherapy plus transarterial chemoembolization for hepatocellular carcinoma invading the portal vein: long-term patient outcomes.
    Yoon SM, Lim YS, Won HJ, Kim JH, Kim KM, Lee HC, Chung YH, Lee YS, Lee SG, Park JH, Suh DJ.
    Int J Radiat Oncol Biol Phys; 2012 Apr 01; 82(5):2004-11. PubMed ID: 21621346
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Arterial portography during transarterial chemoembolization: still a necessity in the age of contrast-enhanced cross-sectional imaging?
    Hui TC, Pua U.
    J Vasc Interv Radiol; 2014 Jan 01; 25(1):41-6. PubMed ID: 24290098
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Post-hepatectomy survival in advanced hepatocellular carcinoma with portal vein tumor thrombosis.
    Yamamoto Y, Ikoma H, Morimura R, Shoda K, Konishi H, Murayama Y, Komatsu S, Shiozaki A, Kuriu Y, Kubota T, Nakanishi M, Ichikawa D, Fujiwara H, Okamoto K, Sakakura C, Ochiai T, Otsuji E.
    World J Gastroenterol; 2015 Jan 07; 21(1):246-53. PubMed ID: 25574098
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.